Blood pressure, lowering it that is, was raised in the recent research that the type 2 diabetics should be considered to have antihypertensive treatment. Why? Because they found out that of the 11,140 diabetic patients in their study, the risk for kidney disease was reduced by 21%. The risk was also decreased among those who did not have high blood pressure.
There is also news that lowering the blood pressure provided some help to type 2 diabetes patients. For these patients, lowering the blood pressure with perindopril-indapamide lowered the risk for kidney disease as well. This is how they found this out.
The guidelines suggest that the type 2 diabetics should have systolic pressure under 130 according to Rhonda M. Cooper-DeHoff, who also has PharmD and is associate professor of medicine and pharmacy at Gainesville's University of Florida.
She conducted a study on this very issue and found out that those whose systolic pressures were moderately controlled did just as well as those whose blood pressure was under tight control. Systolic pressure of course is the upper of the two numbers that represents the maximum pressure applied when the heart contracts.
The researchers studied the possible benefits of getting the blood pressure below the present recommendations for the diabetics which is 130 mm Hg/80 mm Hg as well as for nephropathy which is 125 mm Hg/75 mm Hg. The examiners followed these people up for the mean figure of 4.3 years.
Here's another side of this story. The guidelines suggest that the type 2 diabetics should have systolic pressure under 130 according to Rhonda M. Cooper-DeHoff, who also has PharmD and is associate professor of medicine and pharmacy at Gainesville's University of Florida.
She conducted a study on this very issue and found out that those whose systolic pressures were moderately controlled did just as well as those whose blood pressure was under tight control. Systolic pressure of course is the upper of the two numbers that represents the maximum pressure applied when the heart contracts. You will get more information on hypertension right here.
The number of participants included 11,140 diabetics who also were in the ADVANCE study. The patients were randomly assigned to take a placebo or a combination of perindopril-indapamide. The researchers found out that those patients who were assigned to the blood pressure-lowering drugs decreased their risk for kidney disease by 21%
Those who did not have high blood pressure at the start also reduced their risk for kidney disease when they were given blood pressure-lowering drugs. This finding showed the need for patients to receive antihypertensive treatment even if they had normal blood pressure.
2 comments:
you have written a very informative post. Today, science is advancing at so rapid pace that soon there will be ultimate solution for diabetes. Till then the diabetic patients have to depend on the symtoms of diabetes. Anyway, thank you for the post.
Post a Comment